Protocol Ledger

NCT07393555 · Phase II · RECRUITING

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Interventional Phase II clinical trial protocol NCT07393555 sponsored by SWOG Cancer Research Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-09-22 Enrollment: 117 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07393555
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)117 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07393555
Protocol FieldVerified Registry Value
NCT IdentifierNCT07393555
Consolidated Lead SponsorSWOG Cancer Research Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment117 participants (ESTIMATED)
Registered Start Date2026-09-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI